News
DGAP-News: Abivax phase 2b study results of obefazimod (ABX464) in ulcerative colitis published in the Lancet Gastroenterology & Hepatology
DGAP-News: Abivax phase 2b study results of obefazimod (ABX464) in ulcerative colitis published in the Lancet Gastroenterology & Hepatology
DGAP-News: Formycon publishes preliminary figures for the first half of 2022
DGAP-News: Formycon publishes preliminary figures for the first half of 2022
Spexis provides business update and announces financial results for the first half of 2022
Spexis provides business update and announces financial results for the first half of 2022
Dufry presents new strategy «Destination 2027» at Capital Markets Day
Dufry presents new strategy «Destination 2027» at Capital Markets Day
Lonza and Touchlight collaborate on end-to-end mRNA offering
Lonza and Touchlight collaborate on end-to-end mRNA offering
DGAP-Adhoc: Porsche Automobil Holding SE resolves to further pursue possible acquisition of 25% plus one share of the ordinary shares in Dr. Ing. h.c. F. Porsche AG in connection with IPO
DGAP-Adhoc: Porsche Automobil Holding SE resolves to further pursue possible acquisition of 25% plus one share of the ordinary shares in Dr. Ing. h.c. F. Porsche AG in connection with IPO
DGAP-Adhoc: Mister Spex SE: Adjustment of full year 2022 guidance
DGAP-Adhoc: Mister Spex SE: Adjustment of full year 2022 guidance
MedinCell Secures Additional 20 Million Euros Financing With the European Investment Bank (EIB)
The approval obtained by the EIB is for a new credit facility of 40 million euros
The new credit facility foresees that MedinCell repays in anticipation a previous 20 million euros loan signed in
Rights and Issues Investment Trust PLC: Transaction in Own Shares
Rights and Issues Investment Trust PLC: Transaction in Own Shares
PhosAgro PJSC: PhosAgro Shares to Be Included in Moscow Exchange Blue Chip Index as of 16 September
PhosAgro PJSC: PhosAgro Shares to Be Included in Moscow Exchange Blue Chip Index as of 16 September
CORRECTING and REPLACING : Technip Energies to Address Attendees at the Barclays CEO Energy-Power Conference
Regulatory News:
This replaces the announcement made at 7:30 AM CET on September 5 due to the following corrections: Technip Energies presentation to the Barclays CEO Energy Power conference
Form 8.3 - The Vanguard Group, Inc.: Tullow Oil plc
Form 8.3 - The Vanguard Group, Inc.: Tullow Oil plc
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: Euromoney Institutional Investor plc
Form 8.3 - The Vanguard Group, Inc.: Euromoney Institutional Investor plc
Form 8.3 - The Vanguard Group, Inc.: Darktrace plc
Form 8.3 - The Vanguard Group, Inc.: Darktrace plc